Sam Chun Dang Pharm (000250)
삼천당제약 KOSDAQ 의약품 제조업
Close (Aug 19, 2026)
₩179,600
-2.76%
Market cap
₩4T ($3.0B)
52-week range
₩120,000 –
₩1,233,000
P/E · P/B · Div yield
794.69 · 15.13 ·
0.03%
View chart data as a table
| Date | Close | Foreign net | Institutions | Retail |
|---|---|---|---|---|
| 2026-08-19 | ₩179,600 | ₩-0.2bn | ₩-0.6bn | +₩0.6bn |
| 2026-08-18 | ₩184,700 | ₩-5.2bn | ₩-4.4bn | +₩9.5bn |
| 2026-08-14 | ₩189,000 | ₩-8.8bn | ₩-3.9bn | +₩12.8bn |
| 2026-08-13 | ₩189,800 | +₩6.0bn | ₩-0.2bn | ₩-5.7bn |
| 2026-08-12 | ₩186,200 | ₩-4.4bn | +₩0.1bn | +₩4.1bn |
| 2026-08-11 | ₩191,700 | ₩-23.1bn | ₩-3.8bn | +₩26.4bn |
| 2026-08-10 | ₩188,800 | ₩-2.3bn | +₩12.6bn | ₩-10.6bn |
| 2026-08-07 | ₩164,700 | +₩4.5bn | ₩-3.7bn | ₩-0.8bn |
| 2026-08-06 | ₩165,100 | ₩-2.0bn | +₩0.8bn | +₩1.0bn |
| 2026-08-05 | ₩166,600 | ₩-2.5bn | ₩-1.5bn | +₩3.9bn |
| 2026-08-04 | ₩167,300 | ₩-1.0bn | +₩7.7bn | ₩-6.6bn |
| 2026-08-03 | ₩158,300 | +₩1.8bn | +₩1.7bn | ₩-3.7bn |
| 2026-07-31 | ₩149,600 | +₩5.8bn | +₩3.8bn | ₩-9.4bn |
| 2026-07-30 | ₩129,900 | ₩-1.5bn | +₩2.1bn | ₩-3.7bn |
| 2026-07-29 | ₩126,500 | +₩7.8bn | +₩3.4bn | ₩-11.7bn |
| 2026-07-28 | ₩139,500 | +₩3.5bn | +₩2.3bn | ₩-6.2bn |
| 2026-07-27 | ₩149,400 | +₩1.4bn | +₩6.6bn | ₩-8.1bn |
| 2026-07-24 | ₩148,800 | ₩-9.8bn | ₩-1.1bn | +₩10.8bn |
| 2026-07-23 | ₩166,100 | +₩0.4bn | +₩1.6bn | ₩-2.5bn |
| 2026-07-22 | ₩152,800 | ₩-11.4bn | ₩-5.7bn | +₩15.5bn |
| 2026-07-21 | ₩167,800 | ₩-89.5bn | ₩-19.5bn | +₩105.3bn |
| 2026-07-20 | ₩239,000 | ₩-4.5bn | ₩-3.6bn | +₩8.3bn |
| 2026-07-16 | ₩184,100 | +₩2.6bn | ₩-2.3bn | ₩-0.3bn |
| 2026-07-15 | ₩191,600 | +₩5.1bn | ₩-0.3bn | ₩-5.5bn |
| 2026-07-14 | ₩180,000 | +₩3.1bn | ₩-0.2bn | ₩-3.1bn |
| 2026-07-13 | ₩184,900 | ₩-0.9bn | ₩-1.5bn | +₩2.2bn |
| 2026-07-10 | ₩199,600 | ₩-2.4bn | +₩2.2bn | ₩-0.4bn |
| 2026-07-09 | ₩192,900 | +₩2.6bn | +₩1.5bn | ₩-4.0bn |
| 2026-07-08 | ₩189,000 | +₩0.3bn | ₩-0.1bn | +₩0.2bn |
| 2026-07-07 | ₩201,000 | +₩0.5bn | +₩1.8bn | ₩-1.7bn |
| 2026-07-06 | ₩204,500 | +₩0.8bn | ₩-2.5bn | +₩1.5bn |
| 2026-07-03 | ₩214,000 | +₩0.4bn | +₩0.9bn | ₩-1.4bn |
| 2026-07-02 | ₩204,000 | +₩2.5bn | ₩-3.6bn | +₩1.4bn |
| 2026-07-01 | ₩223,500 | ₩-3.1bn | +₩1.7bn | +₩0.8bn |
| 2026-06-30 | ₩226,000 | ₩-8.6bn | +₩2.1bn | +₩7.0bn |
| 2026-06-29 | ₩238,500 | +₩6.0bn | +₩5.0bn | ₩-10.7bn |
| 2026-06-26 | ₩210,500 | +₩4.5bn | +₩4.1bn | ₩-8.2bn |
| 2026-06-25 | ₩228,000 | +₩5.3bn | ₩-2.3bn | ₩-2.0bn |
| 2026-06-24 | ₩238,500 | +₩3.3bn | +₩3.9bn | ₩-7.0bn |
| 2026-06-23 | ₩223,500 | +₩12.6bn | +₩4.6bn | ₩-17.4bn |
| 2026-06-22 | ₩241,500 | +₩9.0bn | +₩2.1bn | ₩-12.2bn |
| 2026-06-19 | ₩253,500 | +₩6.8bn | +₩2.6bn | ₩-9.3bn |
| 2026-06-18 | ₩263,000 | ₩-5.7bn | +₩0.0bn | +₩4.8bn |
| 2026-06-17 | ₩276,500 | ₩-1.6bn | +₩10.3bn | ₩-9.0bn |
| 2026-06-16 | ₩265,000 | ₩-0.0bn | ₩-3.2bn | +₩2.6bn |
| 2026-06-15 | ₩266,000 | +₩6.3bn | +₩2.4bn | ₩-8.8bn |
| 2026-06-12 | ₩261,500 | ₩-25.6bn | ₩-11.0bn | +₩36.7bn |
| 2026-06-11 | ₩263,000 | +₩5.3bn | ₩-8.3bn | +₩3.7bn |
| 2026-06-10 | ₩258,500 | ₩-6.1bn | ₩-2.5bn | +₩9.1bn |
| 2026-06-09 | ₩242,500 | +₩5.1bn | ₩-3.5bn | ₩-1.7bn |
| 2026-06-08 | ₩239,000 | +₩40.4bn | ₩-2.6bn | ₩-38.1bn |
| 2026-06-05 | ₩292,000 | ₩-9.8bn | ₩-3.8bn | +₩14.3bn |
| 2026-06-04 | ₩309,500 | +₩7.1bn | ₩-1.3bn | ₩-5.6bn |
| 2026-06-02 | ₩302,000 | +₩25.4bn | +₩3.1bn | ₩-28.7bn |
| 2026-06-01 | ₩326,500 | +₩12.7bn | +₩11.4bn | ₩-22.9bn |
| 2026-05-29 | ₩339,000 | ₩-42.8bn | ₩-0.3bn | +₩42.6bn |
| 2026-05-28 | ₩338,000 | +₩11.6bn | +₩1.1bn | ₩-12.5bn |
| 2026-05-27 | ₩351,500 | +₩0.5bn | +₩3.9bn | ₩-4.4bn |
| 2026-05-26 | ₩362,500 | ₩-16.2bn | +₩4.2bn | +₩12.8bn |
| 2026-05-22 | ₩372,000 | ₩-4.5bn | +₩5.6bn | ₩-2.7bn |
| 2026-05-21 | ₩355,000 | +₩2.7bn | +₩0.3bn | ₩-3.7bn |
Investor flows summary
| Window | Foreign | (USD) | Institutions | Retail |
|---|---|---|---|---|
| 1 day | ₩-0.2bn | $-0M | ₩-0.6bn | +₩0.6bn |
| 5 days | ₩-12.6bn | $-9M | ₩-8.9bn | +₩21.3bn |
| 20 days | ₩-41.1bn | $-29M | +₩17.9bn | +₩15.5bn |
Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.
Annual financials
| Fiscal year | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| 2023 | ₩193bn ($137M) | – | ₩10bn ($7M) | -₩4bn (-$3M) |
| 2024 | ₩211bn ($150M) | +9.50% | ₩3bn ($2M) | -₩5bn (-$4M) |
| 2025 | ₩232bn ($164M) | +9.90% | ₩8bn ($6M) | ₩12bn ($9M) |
Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1410.07/$) for reference only.